✦ LIBER ✦

Switching From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Liver Transplant Patients With Gastrointestinal Complications

✍ Scribed by L. Barrera-Pulido; J.M. Álamo-Martínez; L.M. Marín-Gómez; G. Suárez-Artacho; C. Bernal-Bellido; D. Domínguez-Usero; L. Tallón-Aguilar; F. Pareja-Ciuró; J.M. Sousa-Martín; I. García-González; M.A. Gómez-Bravo

Book ID: 116935348
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 361 KB
Volume: 41
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2009.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal Transplant Patients With Gastroint

Renal Transplant Patients With Gastrointestinal Intolerability to Mycophenolate Mofetil: Conversion to Enteric-Coated Mycophenolate Sodium

✍ N. Calvo; A.I. Sanchez-Fructuoso; J. Conesa; A. Moreno; A. Barrientos 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Successful Conversion From Mycophenolate

Successful Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium (Myfortic) in Liver Transplant Patients With Gastrointestinal Side Effects

✍ G. Robaeys; D. Cassiman; C. Verslype; D. Monbaliu; R. Aerts; J. Pirenne; F. Neve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Improvement of gastrointestinal symptoms

Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients

✍ Alexander H. Toledo; Laura Hendrix; Valorie Buchholz; Erin Fisher; Kimberly Newt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

229 SUCCESSFUL CONVERSION FROM MYCOPHENO

229 SUCCESSFUL CONVERSION FROM MYCOPHENOLATE MOFETIL TO ENTERIC-COATED MYCOPHENOLATE SODIUM (MYFORTIC®) IN LIVER TRANSPLANT PATIENTS WITH GASTROINTESTINAL SIDE EFFECTS

✍ G. Robaeys; D. Cassiman; C. Verslype; D. Monbaliu; R. Aerts; J. Pirenne; F. Neve 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Conversion from mycophenolate mofetil to

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study

✍ Jérôme Dumortier; Marie-Claude Gagnieu; Janine Salandre; Olivier Guillaud; Phili 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of this prospective study was to evaluate the effect of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in liver transplant patients

Conversion From Mycophenolate Mofetil to

Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients With Gastrointestinal Tract Disorders

✍ P. Darji; R. Vijayaraghavan; C.M. Thiagarajan; R.K. Sharma; B. Subbarao; R. Pish 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 342 KB